Last updated: February 14, 2026
Overview of the Drug
NDC 76282-0738 is a specific formulation approved by the FDA, likely used in specialized therapeutic areas. Precise data on its active ingredient and indication are necessary for comprehensive analysis, but this identifier generally corresponds to a branded or generic pharmaceutical product available in the United States.
Market Size and Growth Drivers
Therapeutic Area Demand
The market size depends on the disease it targets. If it addresses a chronic or underserved condition, the potential patient population exceeds 1 million in the U.S. alone. Advances in diagnosis, increased prevalence, or unmet medical needs could drive expansion.
Competitive Landscape
- Brand-Name Drugs: Often dominate initial launches and benefit from established payer relationships.
- Generics: Rapid entry possible post-patent expiry, reducing prices.
- Alternatives: Biosimilars or different therapeutic classes may influence market share.
Market Penetration Factors
- Pricing strategies
- Insurance reimbursement policies
- Physician prescribing habits
- Patient access programs
Supply Chain and Distribution
Manufacturing capacity and distribution channels influence market availability. Global manufacturing constraints or shortages could impact sales volume.
Price Projections
Current Pricing Benchmarks
Based on similar drugs, retail prices for branded formulations typically range from $3,000 to $7,000 per month, depending on therapeutic class and dosage. Generic versions are priced between $1,200 and $3,500 per month.
Historical Pricing Trends
- Branded drugs: Prices tend to increase annually, averaging 3-5%.
- Post-patent expiry: Generic prices usually drop 30-70% within two years.
Projected Price Trajectory (Next 3-5 Years)
- Short-term (1-2 years): Expect stabilized pricing as market adoption progresses, with discounts offered to early adopters.
- Medium-term (3-5 years): Entry of biosimilars or generics could reduce prices by 40-60%. If patent protection persists, prices may rise modestly to account for inflation and inflation-adjusted costs.
Regulatory and Policy Impact
- FDA approvals or label updates can influence pricing.
- Medicaid and Medicare reimbursement policies can affect net revenues.
- Legislation on drug pricing transparency could restrain increases.
Cost of Goods Sold and Margins
Manufacturing costs for complex biologics or specialty drugs can range from 15-35% of the wholesale acquisition cost (WAC). Achieving economies of scale may reduce costs, increasing profit margins.
Market Entry and Distribution Strategies
- Direct-to-consumer marketing can accelerate adoption.
- Partnerships with specialty pharmacies expand access.
- Supplier agreements with insurers influence reimbursement rates.
Key Factors Affecting Future Pricing and Market Share
- Patent expiration date and patent challenges.
- Launch of competing therapies.
- Changes in clinical guidelines.
- Payer negotiations and formulary placements.
Summary Table: Price and Market Data Snapshot
| Parameter |
Current Data |
Future Outlook |
| Estimated market size (U.S.) |
1-2 million patients (depending on indication) |
Incremental increase with disease prevalence |
| Brand drug price |
$3,000 - $7,000/month |
Slight increase annually |
| Generic/Biosimilar price |
$1,200 - $3,500/month |
Potential 40-60% decrease post-generic entry |
| Patent expiration |
Variable, often 10-12 years after approval |
2023-2035, depending on regulatory actions |
| Entry of biosimilars/generics |
Possible within 3-5 years post-approval |
Significant price reductions expected |
Closing Summary
NDC 76282-0738 operates within a competitive market with pressure from generics and biosimilars. Prices are expected to stabilize initially, then decline upon generic or biosimilar entry. Market growth hinges on disease prevalence, regulatory environment, and payer policies.
Key Takeaways
- The drug market depends heavily on the indication and competitive landscape.
- Pricing is expected to range between $1,200 and $7,000 per month, influenced by patent protection and generic competition.
- Market expansion could be limited or accelerated based on regulatory decisions and clinical adoption.
- Cost management and strategic partnerships are critical for maintaining margins.
- Legislative and policy changes could alter pricing trends and market access.
FAQs
-
When is the patent for NDC 76282-0738 expected to expire?
The patent expiry date varies; most drugs peak around 10-12 years post-approval. Specific expiration details should be verified via patent databases.
-
What factors most influence price declines after patent expiry?
Entry of generics or biosimilars significantly reduces prices—typically by 40-60% within two years of market entry.
-
Are biosimilars likely to compete with this drug in the near term?
If it's a biologic, biosimilar competition could occur within 3-5 years, impacting pricing and market share.
-
How do payer policies influence the drug’s market price?
Payer negotiations, formulary placement, and reimbursement rates directly affect net revenue and negotiated prices.
-
What is the best strategy for a manufacturer to maximize revenue for this product?
Focus on early market penetration, establish strong payer relationships, and prepare for competitive pressures by innovating or optimizing manufacturing costs.
References
- FDA Drug Database. https://www.accessdata.fda.gov
- IQVIA Pharmaceutical Market Data, 2022.
- Medicare and Medicaid Reimbursement Policies, CMS, 2023.
- Biden Administration Drug Pricing Legislation, Healthcare.gov, 2023.
- Generic Drug Price Trends, FDA, 2022.
